We are live on ! Find out more
GLG Partners

GLG Partners Portfolio holdings

AUM $2.14B Turnover 59.22%
1-Year Est. Return 21.14%
This Fund
S&P 500
This Quarter Est. Return
+5.42%
1 Year Est. Return
+21.14%
3 Year Est. Return
+49.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.14B
AUM Growth
+$251M
Cap. Flow
-$130M
Cap. Flow %
-6.09%
Top 10 Hldgs %
20.07%
Holding
564
New
243
Increased
78
Reduced
76
Closed
91
Avg Time Held Equity + Options
0.6 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.3 years
Avg Time Held Equity only
0.7 years
Top 10 Avg Time Held Equity only
0.2 years
Top 20 Avg Time Held Equity only
0.4 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 27.22%
2 Consumer Discretionary 13.47%
3 Technology 9.7%
4 Financials 9.51%
5 Industrials 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
MSI icon
376
Motorola Solutions
MSI
$89B
$67K ﹤0.01%
+741
New +$67.5K
2017 Q4
0 quarters
DFS icon
377
DELISTED
Discover Financial Services
DFS
$65K ﹤0.01%
+846
New +$58.2K
2017 Q4
0 quarters
IMUX icon
378
Immunic
IMUX
$103M
$65K ﹤0.01%
+27
New +$59.7K
2017 Q4
0 quarters
PCG icon
379
PG&E
PCG
$30B
$64K ﹤0.01%
+1,436
New +$80.4K
2017 Q4
0 quarters
SCCO icon
380
Southern Copper
SCCO
$135B
$61K ﹤0.01%
+1,423
New +$55.9K
2017 Q4
0 quarters
SENS icon
381
Senseonics Holdings
SENS
$612M
$61K ﹤0.01%
+1,139
New +$63.3K
2017 Q4
0 quarters
DTE icon
382
DTE Energy
DTE
$29.3B
$57K ﹤0.01%
+612
New +$58.2K
2017 Q4
0 quarters
CAH icon
383
Cardinal Health
CAH
$65.7B
$54K ﹤0.01%
+880
New +$54.4K
2017 Q4
0 quarters
LEE icon
384
Lee Enterprises
LEE
$162M
$50K ﹤0.01%
+2,130
New +$49.9K
2017 Q4
0 quarters
SRCL icon
385
DELISTED
Stericycle
SRCL
$50K ﹤0.01%
+729
New +$49.5K
2017 Q4
0 quarters
MANT
386
DELISTED
ManTech International
MANT
$50K ﹤0.01%
1,000
-3,000
-75% -$146K
2017 Q2
2 quarters
AWK icon
387
American Water Works
AWK
$30.2B
$47K ﹤0.01%
+509
New +$45K
2017 Q4
0 quarters
LEG icon
388
DELISTED
Leggett & Platt
LEG
$47K ﹤0.01%
+995
New +$47K
2017 Q4
0 quarters
GE icon
389
GE Aerospace
GE
$342B
$46K ﹤0.01%
+553
New +$52.8K
2017 Q4
0 quarters
AEE icon
390
Ameren
AEE
$32B
$40K ﹤0.01%
+684
New +$42K
2017 Q4
0 quarters
GPC icon
391
Genuine Parts
GPC
$17.1B
$40K ﹤0.01%
+416
New +$38K
2017 Q4
0 quarters
VNO icon
392
Vornado Realty Trust
VNO
$6.45B
$39K ﹤0.01%
+499
New +$38.2K
2017 Q4
0 quarters
FFIV icon
393
F5
FFIV
$17.2B
$38K ﹤0.01%
+290
New +$36K
2017 Q4
0 quarters
TRV icon
394
Travelers Companies
TRV
$83B
$37K ﹤0.01%
+272
New +$35.9K
2017 Q4
0 quarters
DRI icon
395
Darden Restaurants
DRI
$26.1B
$34K ﹤0.01%
+358
New +$30.2K
2017 Q4
0 quarters
MAA icon
396
Mid-America Apartment Communities
MAA
$13.7B
$33K ﹤0.01%
+324
New +$33.6K
2017 Q4
0 quarters
CINF icon
397
Cincinnati Financial
CINF
$29.4B
$32K ﹤0.01%
+429
New +$31.9K
2017 Q4
0 quarters
UHS icon
398
Universal Health Services
UHS
$11.5B
$29K ﹤0.01%
+253
New +$27K
2017 Q4
0 quarters
SEE icon
399
DELISTED
Sealed Air
SEE
$27K ﹤0.01%
+544
New +$25K
2017 Q4
0 quarters
SIG icon
400
Signet Jewelers
SIG
$4.19B
$27K ﹤0.01%
475
-59,168
-99% -$3.62M
2015 Q4
8 quarters

Similar funds

GLG Partners's Q4 2017 Portfolio in Review

As of Q4 2017, GLG Partners held 564 positions worth $2.14B, up 13% from $1.89B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

GLG Partners withdrew a net $130M in Q4 2017, closing 91 positions and reducing 76 holdings. Its most notable exit was Sciclone Pharmaceuticals, an estimated $29M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, down from 36% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, GLG Partners opened a new position in Advanced Accelerator Applications S.A. worth $49.2M.

  • GLG Partners's largest Q4 2017 buy was Advanced Accelerator Applications S.A.: 603,055 shares worth $49.2M.
  • GLG Partners added most to NXP Semiconductors in Q4 2017, an estimated $35M increase.
  • GLG Partners's biggest Q4 2017 reduction was Criteo, cutting an estimated $22.5M.
  • GLG Partners fully exited Sciclone Pharmaceuticals in Q4 2017, selling an estimated $29M.
  • GLG Partners's ten largest holdings make up 20% of its $2.14B portfolio in Q4 2017.
  • GLG Partners opened 243 new positions and closed 91 in Q4 2017.
  • GLG Partners's portfolio value rose 13% quarter-over-quarter to $2.14B.

Based on GLG Partners's 13F filing for Q4 2017, filed 14 Feb 2018.